Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aimee M Hunter

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Psycho-Oncology|June 4, 2014
Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot studyAimee M Hunter, Lorna Kwan, Linda M Ercoli, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 8, 2005
Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placeboAimee M Hunter, Andrew F Leuchter, Melinda L Morgan, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|April 29, 2014
Heart rate variability and treatment outcome in major depression: a pilot studyFelipe A Jain, Ian A Cook, Andrew F Leuchter, et al.
Brain Imaging and Behavior|August 20, 2013
Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaintsLinda M Ercoli, Steven A Castellon, Aimee M Hunter, et al.
Journal of Psychiatric Research|April 15, 2014
Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot projectAndrew F Leuchter, James J McGough, Alexander S Korb, et al.
Brain and Behavior|April 4, 2019
Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive DisorderAimee M Hunter, Michael J Minzenberg, Ian A Cook, et al.
Frontiers in Neurology|April 21, 2017
Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development?Michael K Leuchter, Elissa J Donzis, Carlos Cepeda, et al.
Cerebral Cortex (New York, N.Y. : 1991)|April 7, 2019
Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive DisorderJuliana Corlier, Andrew Wilson, Aimee M Hunter, et al.
Clinical EEG and Neuroscience|December 3, 2008
Changes in brain function during administration of venlafaxine or placebo to normal subjectsAndrew F Leuchter, Ian A Cook, David J DeBrota, et al.
The Journal of Clinical Psychiatry|February 20, 2013
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trialIan A Cook, Aimee M Hunter, William S Gilmer, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Psycho-Oncology|June 4, 2014
Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot studyAimee M Hunter, Lorna Kwan, Linda M Ercoli, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 8, 2005
Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placeboAimee M Hunter, Andrew F Leuchter, Melinda L Morgan, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|April 29, 2014
Heart rate variability and treatment outcome in major depression: a pilot studyFelipe A Jain, Ian A Cook, Andrew F Leuchter, et al.
Brain Imaging and Behavior|August 20, 2013
Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaintsLinda M Ercoli, Steven A Castellon, Aimee M Hunter, et al.
Journal of Psychiatric Research|April 15, 2014
Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot projectAndrew F Leuchter, James J McGough, Alexander S Korb, et al.
Brain and Behavior|April 4, 2019
Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive DisorderAimee M Hunter, Michael J Minzenberg, Ian A Cook, et al.
Frontiers in Neurology|April 21, 2017
Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development?Michael K Leuchter, Elissa J Donzis, Carlos Cepeda, et al.
Cerebral Cortex (New York, N.Y. : 1991)|April 7, 2019
Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive DisorderJuliana Corlier, Andrew Wilson, Aimee M Hunter, et al.
Clinical EEG and Neuroscience|December 3, 2008
Changes in brain function during administration of venlafaxine or placebo to normal subjectsAndrew F Leuchter, Ian A Cook, David J DeBrota, et al.
The Journal of Clinical Psychiatry|February 20, 2013
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trialIan A Cook, Aimee M Hunter, William S Gilmer, et al.
Pageof 6